NORTHFIELD, Illinois—Medline Inc., a private manufacturer and distributor of medical supply products, announced it has submitted a draft registration statement on form S-1 to the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering (IPO) of its common stock. The company said the number of shares to be offered and the price range for the proposed offering have yet to be determined. The offering is subject to market and other conditions and the completion of the SEC's review process.
Industry sources had previously reported on the planned IPO, which is expected to occur this year. Reuters reported that the company, which is currently owned by private equity, aims to raise more than $5 billion.
"The stock market flotation could value the medical supplies provider at about $50 billion and come as early as the second quarter," Reuters said based on information from unnamed sources.
Medline is owned by investment firms Blackstone and Carlyle, as well as private equity group Hellman and Friedman. In 2021, Medline was acquired by Blackstone, Carlyle and Hellman and Friedman in a $34 million deal. The company has 43,000 employees worldwide and operates in more than 100 countries.